Brief: FDA Says Getinge Removes Vaporizer Sevoflurane Quick-Fil & Expands Recall Of Vaporizer Sevoflurane Maquet Filling
March 3 (Reuters) - FDA: FDA: GETINGE REMOVES VAPORIZER SEVOFLURANE QUICK-FIL AND EXPANDS RECALL OF VAPORIZER SEVOFLURANE MAQUET FILLING FDA: GETINGE'S SOME VAPORIZER SEVOFLURANE MODELS REMOVED & RECALLED DUE TO RISK OF PATIENT & HEALTH CARE PROFESSIONAL EXPOSURE TO HYDROGEN FLUORIDE Further company coverage: [GETIb.ST] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsBrief: CEO Buys SEK 4.7 Million Of Getinge Shares
Johnson & Johnson defeats heart-pump patent claims in US trial (updated)
Johnson & Johnson defeats heart-pump patent claims in US trial
Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
Getinge lags profit estimates as uncertainty curbs investments in medical equipment